Skip to Content

Harrow Inc HROW

Morningstar Rating
$10.95 +0.13 (1.15%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HROW is trading at a 29% discount.
Price
$10.94
Fair Value
$16.55
Uncertainty
Very High
1-Star Price
$38.72
5-Star Price
$8.32
Economic Moat
Jgnmr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HROW is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$10.83
Day Range
$10.6811.00
52-Week Range
$7.6028.25
Bid/Ask
$10.93 / $10.94
Market Cap
$384.54 Mil
Volume/Avg
176,033 / 416,036

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.95
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Harrow Inc is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
217

Comparables

Valuation

Metric
HROW
EYPT
EGRX
Price/Earnings (Normalized)
1.39
Price/Book Value
5.0816.870.34
Price/Sales
2.9524.820.33
Price/Cash Flow
31.401.77
Price/Earnings
HROW
EYPT
EGRX

Financial Strength

Metric
HROW
EYPT
EGRX
Quick Ratio
4.862.141.52
Current Ratio
5.802.352.16
Interest Coverage
0.28−51.185.39
Quick Ratio
HROW
EYPT
EGRX

Profitability

Metric
HROW
EYPT
EGRX
Return on Assets (Normalized)
−1.23%−37.19%6.32%
Return on Equity (Normalized)
−8.12%−77.61%10.51%
Return on Invested Capital (Normalized)
6.71%−61.03%9.73%
Return on Assets
HROW
EYPT
EGRX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADpv$87.4 Bil
MKKGY
Merck KGaA ADRSbhltss$74.3 Bil
HLN
Haleon PLC ADRKhppd$38.5 Bil
VTRS
Viatris IncFwl$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRFssh$12.4 Bil
CTLT
Catalent IncLnygm$10.3 Bil
CURLF
Curaleaf Holdings IncRzx$3.6 Bil
PRGO
Perrigo Co PLCQyts$3.6 Bil
PBH
Prestige Consumer Healthcare IncFqswg$3.5 Bil
GTBIF
Green Thumb Industries IncTrnc$3.1 Bil

Sponsor Center